V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006782 | 330003535 | 0 | 17.1 | Curative (C) | 2017-02-25 | 2017-05-11 | DOXORUBICIN | N | null | 330003743 | DOXORUBICIN |
| 330006783 | 330003537 | 1.7 | 27.5 | null | 2017-05-17 | 2017-05-22 | Mifamurtide weeks 13-36 | N | Y | 330003743 | MIFAMURTIDE |
| 330006784 | 330010291 | 1.72 | 58.1 | Palliative (P) | 2016-04-02 | 2016-04-20 | Trial Unspecified | N | Y | 330004198 | TRIAL |
| 330006785 | 330003542 | null | 95.1 | Neo-adjuvant (N) | 2013-08-10 | 2013-11-22 | Mifamurtide weeks 1-12 | N | N | 330004563 | MIFAMURTIDE |
| 330006786 | 330003543 | null | 83.2 | Curative (C) | null | 2015-04-25 | Cisplatin | null | null | 330004773 | CISPLATIN |
| 330006787 | 330003544 | null | 78.2 | Palliative (P) | 2017-09-06 | 2017-09-10 | OST Euramos 1 Closed Trial - A | Y | Y | 330004796 | DOXORUBICIN |
| 330006788 | 330003546 | 1.04 | 32.5 | Curative (C) | null | 2015-02-01 | METHOTREXATE | N | null | 330004796 | METHOTREXATE |
| 330006789 | 330007902 | 1.81 | null | Curative (C) | 2016-05-14 | 2016-07-23 | Cisplatin 7 day | 2 | N | 330004842 | CISPLATIN |
| 330006790 | 330007902 | 1.65 | 85.1 | null | 2015-03-09 | 2015-03-12 | Cisplatin | 2 | N | 330004842 | CISPLATIN |
| 330006791 | 330003549 | 1.8 | 95.1 | Curative (C) | 2013-08-26 | 2013-09-22 | Cisplatin | 02 | N | 330004950 | CISPLATIN |
| 330006792 | 330003549 | 0 | 73.5 | Palliative (P) | 2014-10-29 | 2014-11-22 | Trial Unspecified | Y | Y | 330004950 | TRIAL |
| 330006795 | 330003551 | 1.82 | 75.5 | Curative (C) | 2013-02-14 | 2013-11-14 | MIFAMURTIDE | 2 | N | 330004962 | MIFAMURTIDE |
| 330006796 | 330007905 | 0 | 66 | Adjuvant (A) | 2017-06-17 | 2017-06-18 | Trial Unspecified | null | N | 330004963 | TRIAL |
| 330006797 | 330003553 | 1.77 | 70 | Curative (C) | 2016-12-05 | 2016-12-27 | Cisplatin | Y | Y | 330004971 | CISPLATIN |
| 330006798 | 330003554 | 1.69 | 47 | Neo-adjuvant (N) | null | 2017-11-15 | OST Mifamurtide | Y | null | 330004974 | MIFAMURTIDE |
| 330006799 | 330003554 | 1.6 | null | Neo-adjuvant (N) | 2017-04-07 | 2017-10-23 | EW EuroEwing 2012 Arm B IE | 02 | N | 330004974 | TRIAL |
| 330006800 | 330003557 | null | 56.7 | Curative (C) | 2015-10-11 | 2016-04-18 | OST Mifamurtide | 02 | N | 330005004 | MIFAMURTIDE |
| 330006801 | 330003559 | 0 | 18.1 | Curative (C) | 2016-05-19 | 2016-06-08 | EW EuroEwing 2012 Arm B VDC | Y | N | 330005014 | TRIAL |
| 330006802 | 330003559 | 0 | 99.8 | Palliative (P) | 2017-10-08 | 2017-10-09 | Trial Unspecified | Y | N | 330005014 | TRIAL |
| 330006803 | 330003560 | 1.82 | 27.7 | Curative (C) | null | 2016-08-20 | METHOTREXATE | null | null | 330005054 | METHOTREXATE |
| 330006804 | 330003560 | 1.8 | 75.9 | Adjuvant (A) | 2015-02-13 | 2015-02-23 | MIFAMURTIDE | Y | Y | 330005054 | MIFAMURTIDE |
| 330006805 | 330010301 | 0 | 74 | Curative (C) | null | 2016-04-14 | Trial Unspecified | null | null | 330005070 | TRIAL |
| 330006806 | 330010301 | 0 | 60.5 | Neo-adjuvant (N) | 2014-09-05 | 2014-10-25 | Cisplatin | 02 | N | 330005070 | CISPLATIN |
| 330006807 | 330010301 | 0 | 51.2 | Curative (C) | 2015-10-15 | 2015-11-11 | Cisplatin 7 day | 01 | N | 330005070 | CISPLATIN |
| 330006808 | 330010301 | 0 | 45.6 | Adjuvant (A) | 2018-02-14 | 2018-02-15 | MIFAMURTIDE | Y | N | 330005070 | MIFAMURTIDE |
| 330006809 | 330013238 | 0 | 87.7 | Curative (C) | 2015-11-24 | 2015-12-18 | Cisplatin | Y | null | 330005086 | CISPLATIN |
| 330006810 | 330003561 | 1.79 | 92.3 | Curative (C) | null | 2014-06-16 | Mifamurtide weeks 13-36 | Y | null | 330005089 | MIFAMURTIDE |
| 330006811 | 330003562 | 1.71 | 100 | Disease modification (D) | 2014-12-09 | 2015-03-05 | EW EuroEwing 2012 Arm A VAI | N | N | 330005089 | TRIAL |
| 330006812 | 330003563 | null | 72.6 | Adjuvant (A) | 2014-01-23 | 2014-01-30 | Mifamurtide weeks 13-36 | Y | Y | 330005090 | MIFAMURTIDE |
| 330006813 | 330003567 | 1.71 | 96 | Neo-adjuvant (N) | null | 2016-11-06 | Doxorubicin 75mg/m2 | N | null | 330005103 | DOXORUBICIN |
| 330006814 | 330007916 | 1.72 | 75.1 | Curative (C) | 2016-12-15 | 2016-12-29 | Cisplatin 7 day | N | Y | 330005105 | CISPLATIN |
| 330006815 | 330010303 | 1.79 | 63.6 | Not known (9) | 2017-06-29 | 2017-09-20 | Cisplatin | N | N | 330005108 | CISPLATIN |
| 330006816 | 330003568 | 1.71 | null | Adjuvant (A) | 2017-03-21 | 2017-05-12 | Cisplatin | N | N | 330005121 | CISPLATIN |
| 330006817 | 330003569 | 1.66 | 80.5 | Neo-adjuvant (N) | 2016-01-30 | 2016-02-28 | EW EuroEwing 2012 Arm A VAI | N | N | 330005132 | TRIAL |
| 330006818 | 330003569 | 1.88 | null | null | 2018-06-23 | 2018-06-23 | OST Euramos 1 Closed Trial - A | 01 | N | 330005132 | DOXORUBICIN |
| 330006819 | 330003569 | 1.8 | 27.2 | Curative (C) | 2017-06-18 | 2017-06-18 | Trial Unspecified | null | null | 330005132 | TRIAL |
| 330006820 | 330003571 | 1.6 | 18.1 | null | null | 2014-09-03 | DOXORUBICIN | Y | null | 330005140 | DOXORUBICIN |
| 330006823 | 330010306 | 1.8 | null | Curative (C) | null | 2015-07-26 | Cisplatin 7 day | 2 | N | 330005157 | CISPLATIN |
| 330006824 | 330010306 | 1.8 | 70.6 | Neo-adjuvant (N) | 2015-08-15 | 2015-08-29 | EW EuroEwing 2012 Arm B IE | 02 | Y | 330005157 | TRIAL |
| 330006825 | 330003575 | 0 | 75 | Neo-adjuvant (N) | 2017-08-20 | 2017-08-20 | Trial Unspecified | 02 | null | 330005162 | TRIAL |
| 330006826 | 330007920 | 1.82 | 55 | Neo-adjuvant (N) | null | 2015-01-15 | Cisplatin | null | null | 330005173 | CISPLATIN |
| 330006827 | 330007920 | 1.59 | 74.15 | null | 2015-06-01 | 2015-12-27 | Doxorubicin 75mg/m2 | 02 | N | 330005173 | DOXORUBICIN |
| 330006828 | 330007920 | 1.85 | 61.4 | Disease modification (D) | 2013-12-24 | 2013-12-24 | Cisplatin | 02 | N | 330005173 | CISPLATIN |
| 330006829 | 330003578 | null | null | Curative (C) | 2015-12-22 | 2015-12-28 | DOXORUBICIN | N | N | 330005197 | DOXORUBICIN |
| 330006830 | 330003578 | 1.69 | 88.2 | Curative (C) | 2014-08-06 | 2014-08-19 | EW EuroEwing 2012 Arm A VAI | Y | N | 330005197 | TRIAL |
| 330006831 | 330003579 | 0 | 18.1 | Curative (C) | 2015-11-19 | 2015-12-16 | Cisplatin | null | null | 330005201 | CISPLATIN |
| 330006832 | 330003579 | 1.58 | null | Curative (C) | 2017-11-04 | 2018-01-10 | Cisplatin 7 day | Y | N | 330005201 | CISPLATIN |
| 330006833 | 330003582 | 1.74 | 56.8 | Curative (C) | 2018-04-12 | 2018-05-03 | Cisplatin | N | N | 330005204 | CISPLATIN |
| 330006834 | 330007924 | 1.74 | 59.5 | null | 2016-12-09 | 2016-12-15 | Cisplatin 7 day | 02 | N | 330005212 | CISPLATIN |
| 330006835 | 330003584 | null | 80.5 | Curative (C) | null | 2013-06-13 | Cisplatin | N | null | 330005221 | CISPLATIN |